Cargando…
Towards precision oncology in angiosarcomas using next generation “omic” technologies
Angiosarcomas are a group of aggressive tumors of vascular origin. Although thought to be a rare cancer constituting just 1–2% of all soft tissue sarcomas, recent observations suggest that angiosarcomas are more common amongst Asian populations as compared to the West, suggesting the possibility of...
Autores principales: | Tan, Grace Fangmin, Chan, Jason Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448512/ https://www.ncbi.nlm.nih.gov/pubmed/34548911 http://dx.doi.org/10.18632/oncotarget.27996 |
Ejemplares similares
-
Evolution of Next Generation Therapeutics: Past, Present, and Future of Precision Medicines
por: Ramamoorthy, Anuradha, et al.
Publicado: (2019) -
Toward next-generation fuel cell materials
por: Shah, M.A.K. Yousaf, et al.
Publicado: (2023) -
Deciphering next-generation pharmacogenomics: an information technology perspective
por: Potamias, George, et al.
Publicado: (2014) -
Towards Artificial Intelligence Applications in Next Generation Cytopathology
por: Giarnieri, Enrico, et al.
Publicado: (2023) -
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
por: Regier, Dean A., et al.
Publicado: (2022)